Enavate Sciences

Enavate Sciences is a dedicated platform for supporting therapeutic companies developing innovative medicines and enabling technologies with the potential to address unmet patient needs. The company provides significant capital, personalized attention and strategic growth support, enabling its partner companies to accelerate innovation and realize their full potential. Enavate has a strong commitment to investing in and supporting the strategic growth of companies developing therapies in a broad range of areas, prioritizing growth potential and areas of unmet medical need.

Enavate Sciences is a portfolio company of Patient Square Capital, a leading dedicated health care investment firm. The company is led by James Boylan, an accomplished health care executive with nearly three decades of experience in the life sciences sector. The Enavate team boasts a diverse range of professionals with expertise in company building, drug discovery and development, clinical and market assessments, and comprehensive business development. Enavate Sciences is headquartered in New York City and has a strong network of relationships within the healthcare field.

Enavate Sciences is a dedicated platform focused on supporting the strategic growth of innovative therapeutic and enabling technology companies with the potential to transform patient care and improve quality of life. They prioritize companies that are developing a broad range of therapeutic areas in both pre-clinical and clinical stages, focusing on areas of unmet medical need and growth potential. By providing significant capital, personalized attention, and strategic growth support, Enavate strives to be the partner of choice for life sciences companies and their existing investors, ensuring each company realizes its true potential.

Enavate Sciences promotes a collaborative and supportive culture focused on empowering innovative life sciences companies. They emphasize personalized attention and strategic growth support, working closely with their partners to ensure their success and ultimately improve patient outcomes. This collaborative approach fosters a dynamic environment where talented professionals with diverse backgrounds can contribute to the advancement of novel therapeutics.

Enavate Sciences is committed to fostering a diverse and inclusive workplace. They aim to create a culture that embraces and values diverse perspectives, backgrounds, and experiences. They believe that this approach strengthens their company's ability to innovate and succeed.